Lacosamide Tablets Recalled Nationwide for Manufacturing Deviations
Glenmark Pharmaceuticals is voluntarily recalling Lacosamide Tablets 200mg due to manufacturing quality deviations. The prescription antiseizure medication is distributed nationwide.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is a voluntary, firm-initiated precautionary recall for manufacturing process deviations. Without reported illnesses, injuries, or identified quality defects, it meets the criterion for Score 2 voluntary recalls.
Plain-English summary
Glenmark Pharmaceuticals Inc., USA is voluntarily recalling Lacosamide Tablets 200mg (NDC# 68462-681-60), a prescription antiseizure medication manufactured by Glenmark Pharmaceuticals Limited in India, due to Current Good Manufacturing Practice (CGMP) deviations.
The recall affects 60-count bottles of the 200mg tablets distributed nationwide. Affected lot numbers include: 17230982, 17230986, and 17231001 (expiring April 2025); 17240197, 17240198, and 17240215 (expiring January 2026); and 17240846 and 17240847 (expiring April 2026). Consumers can check their medication bottle for the lot number and expiration date.
Patients taking this medication should contact their pharmacist or healthcare provider if they have an affected lot number. Do not discontinue use without consulting your healthcare provider, as stopping an antiseizure medication abruptly could be harmful. Return any recalled medication to your pharmacy.
Glenmark Pharmaceuticals initiated this voluntary recall on March 13, 2025.
The recalled product
- Product
- LACOSAMIDE (LACOSAMIDE)
- Brand
- LACOSAMIDE
- Manufacturer
- Glenmark Pharmaceuticals Inc., USA
- Category
- Drug — Antiseizure Medication
- Hazard
- manufacturing-defect
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (10)
- Lot # 17230982
- exp. date Apr-25 17230986
- exp. date
- Apr-25 17231001
- Apr-25 17240197
- exp. date Jan-26 17240198
- exp. date Jan-26 17240215
- exp. date Jan-26 17240846
- exp. date Apr-26 17240847
- exp. date Apr-26
UPCs (4)
- 0368462681602
- 0368462679609
- 0368462678602
- 0368462680605
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · LACOSAMIDE
- HighFDA Recalls Lacosamide Tablets for Manufacturing Quality Deviations
FDA (Drugs) · 2025-04-16
- HighLacosamide 50mg Tablets Recalled for Manufacturing Process Deviations
FDA (Drugs) · 2025-04-16
- ModerateLacosamide Tablets Recalled Due to Manufacturing Practice Deviations
FDA (Drugs) · 2025-04-16
- ModerateLacosamide oral solution recalled for failed excipient specifications
FDA (Drugs) · 2022-12-21
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27